Evidence map›Paper›PMID 31774910›Full record

ArticleBioscience reports2019

Tumor suppressor properties of the small C-terminal domain phosphatases in non-small cell lung cancer.

George S Krasnov, Grigory A Puzanov, Marina A Afanasyeva, Erdem B Dashinimaev, Khava S Vishnyakova, Artemy D Beniaminov, Alexei A Adzhubei, Tatiana T Kondratieva, Yegor E Yegorov, Vera N Senchenko

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

George S KrasnovLaboratory of Postgenomic Research, Laboratory of Structural and Functional Genomics, Laboratory of Cellular Basics of Cancer Development, Laboratory of DNA-Protein Interactions, Laboratory of Protein Conformational Polymorphism in Health and Disease, Center for Precision Genome Editing and Genetic Technologies for Biomedicine. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Grigory A PuzanovLaboratory of Postgenomic Research, Laboratory of Structural and Functional Genomics, Laboratory of Cellular Basics of Cancer Development, Laboratory of DNA-Protein Interactions, Laboratory of Protein Conformational Polymorphism in Health and Disease, Center for Precision Genome Editing and Genetic Technologies for Biomedicine. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Marina A AfanasyevaLaboratory of Postgenomic Research, Laboratory of Structural and Functional Genomics, Laboratory of Cellular Basics of Cancer Development, Laboratory of DNA-Protein Interactions, Laboratory of Protein Conformational Polymorphism in Health and Disease, Center for Precision Genome Editing and Genetic Technologies for Biomedicine. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Erdem B DashinimaevLaboratory of Cell Biology, Koltzov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia.
Khava S VishnyakovaLaboratory of Postgenomic Research, Laboratory of Structural and Functional Genomics, Laboratory of Cellular Basics of Cancer Development, Laboratory of DNA-Protein Interactions, Laboratory of Protein Conformational Polymorphism in Health and Disease, Center for Precision Genome Editing and Genetic Technologies for Biomedicine. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Artemy D BeniaminovLaboratory of Postgenomic Research, Laboratory of Structural and Functional Genomics, Laboratory of Cellular Basics of Cancer Development, Laboratory of DNA-Protein Interactions, Laboratory of Protein Conformational Polymorphism in Health and Disease, Center for Precision Genome Editing and Genetic Technologies for Biomedicine. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Alexei A AdzhubeiLaboratory of Postgenomic Research, Laboratory of Structural and Functional Genomics, Laboratory of Cellular Basics of Cancer Development, Laboratory of DNA-Protein Interactions, Laboratory of Protein Conformational Polymorphism in Health and Disease, Center for Precision Genome Editing and Genetic Technologies for Biomedicine. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Tatiana T KondratievaResearch Institute of Clinical Oncology, Blokhin National Medical Research Center of Oncology, Russian Ministry of Health, Moscow, Russia.
Yegor E YegorovLaboratory of Postgenomic Research, Laboratory of Structural and Functional Genomics, Laboratory of Cellular Basics of Cancer Development, Laboratory of DNA-Protein Interactions, Laboratory of Protein Conformational Polymorphism in Health and Disease, Center for Precision Genome Editing and Genetic Technologies for Biomedicine. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Vera N SenchenkoLaboratory of Postgenomic Research, Laboratory of Structural and Functional Genomics, Laboratory of Cellular Basics of Cancer Development, Laboratory of DNA-Protein Interactions, Laboratory of Protein Conformational Polymorphism in Health and Disease, Center for Precision Genome Editing and Genetic Technologies for Biomedicine. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Engelhardt Institute of Molecular Biology · RUMinistry of Health of the Russian Federation · RUPirogov Russian National Research Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-Small Cell Lung Cancer (NSCLC) is responsible for the majority of deaths caused by cancer. Small C-terminal domain (CTD) phosphatases (SCP), CTDSP1, CTDSP2 and CTDSPL (CTDSPs) belong to SCP/CTDSP subfamily and are involved in many vital cellular processes and tumorigenesis. High similarity of their structures suggests similar functions. However their role in NSCLC remains insufficiently understood. For the first time we revealed the suppressor function of CTDSPs leading to a significant growth slowdown and senescence of A549 lung adenocarcinoma (ADC) cells in vitro. Their tumor-suppressive activity can be realized through increasing the proportion of the active form of Rb protein dephosphorylated at Ser807/811, Ser780, and Ser795 (P<0.05) thereby negatively regulating cancer cell proliferation. Moreover, we observed that a frequent (84%, 39/46) and highly concordant (Spearman's rank correlation coefficient (rs) = 0.53-0.62, P≤0.01) down-regulation of CTDSPs and RB1 is characteristic of primary NSCLC samples (n=46). A clear difference in their mRNA levels was found between lung ADCs with and without lymph node metastases, but not in squamous cell carcinomas (SCCs) (P≤0.05). Based on The Cancer Genome Atlas (TCGA) data and the results obtained using the CrossHub tool, we suggest that the well-known oncogenic cluster miR-96/182/183 could be a common expression regulator of CTDSPs. Indeed, according to our qPCR, the expression of CTDSPs negatively correlates with these miRs, but positively correlates with their intronic miR-26a/b. Our results reflect functional association of CTDSP1, CTDSP2, and CTDSPL, expand knowledge about their suppressor properties through Rb dephosphorylation and provide new insights into the regulation of NSCLC growth.

Indexed as

A549 CellsCarcinoma, Non-Small-Cell LungFemaleHumansLung NeoplasmsMalePhosphoprotein PhosphatasesTumor Suppressor ProteinsPhosphoprotein PhosphatasesTumor Suppressor Proteinscell cyclemicroRNASCP/CTDSP phosphatasestumor suppressors

Identifiers

PMID31774910
PMCPMC6911153
OpenAlexW2991315072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.